Treatment of paraneoplastic autoimmune multiorgan syndrome (PAMS) can be challenging; a p53 tumor suppressor mutation adds a further layer of complexity.
Article InformationCorresponding Author: Susan Margaret O'Gorman, MB BCh BAO, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (firstname.lastname@example.org).
Published Online: July 31, 2013. doi:10.1001/jamadermatol.2013.4982.
Conflict of Interest Disclosures: None reported.
Additional Contributions: We are indebted to Alina G. Bridges, DO, for her help with histopathological findings in this case.